Merit Medical Systems, Inc.

Contributing Author

Recent Articles by Merit Medical Systems, Inc.

Sep-04	Merit Medical to Participate in Upcoming Investors Conferences in September MMSI GlobeNewswire
Aug-19	Merit Medical Announces Global Operations Leadership Transition MMSI GlobeNewswire
Aug-05	Merit Medical to Participate in Upcoming Investors Conferences in August MMSI GlobeNewswire
Jul-30	Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance MMSI GlobeNewswire
Jul-02	Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026 MMSI GlobeNewswire
May-19	Merit Medical Shareholders Elect Scott R. Ward to Board of Directors MMSI GlobeNewswire
May-08	Merit Medical to Participate in the Bank of America Healthcare Conference MMSI GlobeNewswire
Apr-30	Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance MMSI +5.15% MMSI -9.05% GlobeNewswire
Apr-02	Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026 MMSI GlobeNewswire
Apr-01	Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio MMSI GlobeNewswire
Mar-16	Merit Medical Launches the Resilience Through-the-Scope Esophageal Stent MMSI GlobeNewswire
Feb-24	Merit Medical Reports Fourth Quarter and Full Year 2025 Results and Issues Fiscal Year 2026 Guidance MMSI GlobeNewswire
Jan-08	Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025 MMSI MMSI -7.30% GlobeNewswire
Dec-23	Merit Medical to Participate at the J.P. Morgan Healthcare Conference MMSI GlobeNewswire
Nov-13	Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY Cell-Impermeable Endoprosthesis MMSI GlobeNewswire
Nov-05	Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial MMSI GlobeNewswire
Nov-03	Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial MMSI GlobeNewswire
Oct-30	Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance MMSI MMSI +5.42% GlobeNewswire
Oct-15	Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology MMSI GlobeNewswire
Oct-03	Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025 MMSI GlobeNewswire
Oct-01	Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology MMSI GlobeNewswire
Sep-12	Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis MMSI -5.19% GlobeNewswire
Aug-18	First Patient Enrolled in Merit Medical's WRAPSODY (WRAP) North America Registry MMSI GlobeNewswire
Aug-07	Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology MMSI GlobeNewswire
Jul-30	Merit Medical Reports Second Quarter 2025 Results and Updates Full-Year Guidance MMSI GlobeNewswire
Jul-07	Merit Medical Names Martha Aronson as New President and Chief Executive Officer MMSI GlobeNewswire
Jul-03	Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025 MMSI GlobeNewswire
May-20	Merit Medical Acquires Biolife Delaware, L.L.C. MMSI GlobeNewswire
May-06	Merit Medical Announces Health Canada Approval of the WRAPSODY Cell-Impermeable Endoprosthesis MMSI GlobeNewswire
May-05	Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Efficacy (WAVE) Trial MMSI GlobeNewswire

Merit Medical Systems, Inc.

Recent Articles by Merit Medical Systems, Inc.

Upgrade your Finviz experience